Artificial Intelligence driven Marketing Communications
Biosurgery is the combination of techniques and surgical techniques to decrease post and intra-operative complications. The global biosurgery market is growing at significant rate, due to expanding geriatric population and mounting number of surgeries. Different product and services contributed to the biosurgery market size. The market has witnessed high demand for bone-graft substitutes in the coming years due to mounting usage of bone-graft substitutes in various types of orthopedic surgeries as they decrease surgical time.
Download Free Report Sample at: https://www.vynzresearch.com/healthcare/biosurgery-market/request-sample
Mounting number of surgeries, mounting prevalence of severe trauma injuries, escalating sports related injuries and robust emphasis on R&D for the launch of novel and innovative products are the primary growth drivers for biosurgery market. For instance, according to American Society of Plastic Surgeons in 2015 approximately 15.9 million cosmetic procedures were performed in the U.S., a two percent increase over 2014.
Geographically, North America is the largest biosurgery market as in the region the geriatric population is increasing. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050.
Explore Full Repoert Description at: https://www.vynzresearch.com/healthcare/biosurgery-market
Asia-Pacific is observed to witness fastest growth in the market, due to expanding geriatric population and refining healthcare infrastructure. In addition, mounting healthcare expenditure, mounting occurrence of chronic diseases and lifestyle associated diseases, escalating number of surgical procedures, and mounting demand for effectual blood loss management are also creating a positive impact on the biosurgery market growth in the region.
Key players in the biosurgery market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In April 2018, Medtronic PLC received FDA approval of Infuse Bone Graft. It is used with spine implants composed of polyetheretherketone in oblique lateral interbody fusion and anterior lumbar interbody fusion procedures. Baxter International, Inc., Medtronic, PLC., Hemostasis, LLC, B.Braun Melsungen AG, Cohera Medical Inc., C.R. Bard, Sanofi, Johnson & Johnson, Getinge Group and Integra Lifesciences Holdings Corporation are the key players offering biosurgery.
About VynZ Research :
VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.
VynZ Research USA
165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Email: [email protected]
Connect With us: Linkedin | Twitter | Facebook | Google+